HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Flushing and haemodynamic responses to vasopressin peptides in the rhesus monkey.

Abstract
1. The mechanism of the flushing, hypotension and tachycardia associated with i.v. administration of desGlyd(CH2)5D-Tyr(Et)VAVP (SK&F 101926; 25 micrograms kg-1) and the selective V2 antidiuretic agonist, desamino-8-D-arginine vasopressin (dDAVP; 3 micrograms kg-1) was studied in ketamine-anaesthetized rhesus monkeys. 2. The flushing associated with SK&F 101926 was reduced by pretreatment with a mast cell stabilizer and by repeated administration of peptide (within 2-4 weeks). A similar desensitization to dDAVP-associated flushing was observed on repeated administration. 3. Treatment with dDAVP also resulted in reduced SK&F 101926-associated flushing. 4. The hypotension associated with SK&F 101926 was not affected by pretreatment with a mast cell stabilizer. A similar degree of hypotension was observed with repeated administration of either SK&F 101926 or dDAVP. 5. The tachycardia associated with SK&F 101926 was reduced by pretreatment with a mast cell stabilizer or repeated administration of SK&F 101926. Repeated administration of dDAVP, however, resulted in an enhanced tachycardia. 6. Indomethacin (5 mg kg-1 i.v.) did not alter the flushing or the hypotension associated with the administration of either SK&F 101926 or dDAVP, but resulted in an enhanced tachycardia to SK&F 101926. 7. Administration of a selective V1 vasopressor antagonist did not result in flushing, hypotension or tachycardia. 8. It was concluded that the flushing response to vasopressin-like peptides in rhesus monkeys may be due to an action on mast cells, whereas the haemodynamic responses are not, but probably involve direct vasodilator actions.
AuthorsD P Brooks, P F Koster, F L Stassen, C R Albrightson, W F Huffman, M A Wasserman, L B Kinter
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 94 Issue 3 Pg. 759-64 (Jul 1988) ISSN: 0007-1188 [Print] ENGLAND
PMID3179611 (Publication Type: Journal Article)
Chemical References
  • Arginine Vasopressin
  • 1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(O-ethyl-Tyr)-4-Val-9-des-Gly-arginine vasopressin
  • Deamino Arginine Vasopressin
  • Indomethacin
Topics
  • Animals
  • Arginine Vasopressin (analogs & derivatives, pharmacology)
  • Blood Pressure (drug effects)
  • Deamino Arginine Vasopressin (pharmacology)
  • Disease Models, Animal
  • Flushing (chemically induced, prevention & control)
  • Heart Rate (drug effects)
  • Hemodynamics (drug effects)
  • Indomethacin (pharmacology)
  • Macaca mulatta
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: